SCHEMBL13715325

SCHEMBL13715325

Oc1cccc2c1c1ccccc1n2-c1cccc(-n2c3ccccc3c3c(O)cccc32)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.48
▸ ATM Q13315 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ MAPT P10636 2/20 0.42
▸ HTT P42858 1/20 0.42
▸ HSD17B10 Q99714 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ TSHR P16473 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ BRCA1 P38398 1/20 0.41
▸ HPGD P15428 2/20 0.41
▸ APP P05067 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ SNCA P37840 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30692086 1.00 KDM4E (0.48) KDM4EATML3MBTL1MAPTHTT
SCHEMBL31257232 0.91 KDM4E (0.61) KDM4EATML3MBTL1MAPTHTT
SCHEMBL10064054 0.91 KDM4E (0.61) KDM4EATML3MBTL1MAPTHTT
SCHEMBL13715474 0.84 L3MBTL1 (0.47) KDM4EATML3MBTL1MAPTHTT
SCHEMBL14924580 0.83 KDM4E (0.59) KDM4EATML3MBTL1MAPTHTT
SCHEMBL13715298 0.83 MAOA (0.38) KDM4EATML3MBTL1MAPTHTT
SCHEMBL16848480 0.82 MAPT (0.35) KDM4EATML3MBTL1MAPTHTT
SCHEMBL10027626 0.81 L3MBTL1 (0.63) KDM4EATML3MBTL1MAPTHTT
SCHEMBL13010496 0.81 MAPT (0.39) KDM4EATML3MBTL1MAPTHSD17B10
SCHEMBL29351958 0.80 L3MBTL1 (0.73) KDM4EATML3MBTL1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117264106-A Efficient thermal-activation delayed fluorescence single-molecule white light polymer with vinyl main chain 江苏海洋大学 2023-12-22 — — CN disclosed
US-8362463-B2 Organometallic complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2013-01-29 — — US disclosed
US-8362463-B2 Organometallic complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2013-01-29 — — US disclosed
US-20090206327-A1 ORGANOMETALLIC COMPLEXES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-08-20 — — US disclosed
US-20090206327-A1 ORGANOMETALLIC COMPLEXES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090206327-A1 ORGANOMETALLIC COMPLEXES SLC25A11, TIMM9, TIMM50 KDM4E 2731/4885ATM 3135/4885L3MBTL1 1088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback